Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Cardiac ablation and mapping
Cardiac mapping enables physicians to characterize abnormal rhythms of the heart by producing biatrial and biventricular 3-D cardiac maps.
The CardioInsight™ Noninvasive 3D Mapping System is a noninvasive mapping system that collects chest ECG signals and combines these signals with CT scan data to produce and display simultaneous, biatrial and biventricular, 3-D cardiac maps. The mapping enables physicians to characterize abnormal rhythms of the heart.
Map anytime outside the EP lab throughout patient care pathway. Supports flexible patient management, procedural planning, and lab use.
Captures and panoramically displays rhythms that span multiple chambers or vary in cycle length, such as atrial fibrillation (AF).
Produce maps with one beat's worth of data for infrequent, unstable rhythms, such as ventricular tachycardia (VT) or specific supraventricular tachycardias (SVTs).
The CardioInsight™ system is based on the unique and patented Electrocardiographic Mapping (ECM) platform that combines body surface electrical data with heart-torso anatomical data to provide simultaneous, biatrial and biventricular 3-D maps of the heart's electrical activity.
The CardioInsight™ system uses a proprietary, single-use, disposable multi-electrode vest to capture electrical signals from the body surface. The CardioInsight™ software provides various cardiac signal analyses and displays interactive 3-D color maps including activation, composite and phase maps.*
The CardioInsight™ system provides the unique opportunity to enable advanced cardiac mapping outside the EP lab.
Watch the video for an overview of the CardioInsight™ system.
This bibliography includes a selection of conferences, abstracts, and peer-reviewed, published data about the ECVUE™ Cardiac Mapping System and CardioInsight™ Noninvasive 3D Mapping System technology.
Access detailed product information, including spec sheets, videos, and presentations.
The clinical significance of solely utilizing phase maps to classify arrhythmia mechanisms has not been validated by clinical investigations.